Hepatitis C: Inequalities in Access to Medicines


Mar 2015 by IMS Health
This study by IMS Health seeks to understand the barriers to more effective treatment for hepatitis C in England. Among its findings were that inequalities in access to hepatitis C treatment are becoming more pronounced, and that treatment rates are actually falling among the most deprived patient groups.
UK, England